NCT05174624 is a clinical trial of No intervention in Healthy, sponsored by Centre for Immunology & Infection.

Who is sponsoring NCT05174624?

NCT05174624 is sponsored by Centre for Immunology & Infection.

What drugs are being tested in NCT05174624?

Interventions in NCT05174624: No intervention.

What condition does NCT05174624 study?

NCT05174624 studies Healthy, Immune System and Related Disorders.

Is NCT05174624 still recruiting?

NCT05174624 is currently completed. Last updated 4 October 2023.

Last reviewed 2023-10-04 · How we verify

NCT05174624

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)

Completed Last updated 4 October 2023

What this trial tests

trial testing No intervention in Healthy in 1,026 participants. Completed in 14 September 2023.

Timeline

1 July 2022

Primary endpoint
14 September 2023

14 September 2023

Quick facts

Lead sponsor	Centre for Immunology & Infection
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,026
Start date	1 July 2022
Primary completion	14 September 2023
Estimated completion	14 September 2023
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Healthy — all drugs for Healthy →
Immune System and Related Disorders — all drugs for Immune System and Related Disorders →

Sponsor

Centre for Immunology & Infection

Who can join

Adults 20 to 79, any sex, with Healthy or Immune System and Related Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Healthy Human Global Project-Hong Kong aims to elucidate the heritable and non-heritable factors that drive immunological variance within a healthy population in Hong Kong. By gaining a deeper understanding of these parameters, a path can be paved for personalised and precision medicine, tailored for an Asian population.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses.
Ng WW, Sugrue J, Rosa Duque JS, Rouilly V, et al · · 2026 · PMID 42139359 · DOI 10.1126/sciadv.aed8930
The healthy human global project - Hong Kong: A community-based cross-sectional study of a healthy Asian population.
Hung RL, Ng WW, Chung PKC, Li ABS, et al · · 2026 · PMID 41916291 · DOI 10.1016/j.xcrm.2026.102701

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05174624 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre for Immunology & Infection
Last refreshed: 4 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05174624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing